Quantcast

Latest Influenza treatment Stories

2008-08-01 06:00:46

Biota Holdings has announced that its second generation, influenza treatment, CS-8958, has successfully completed its initial Phase II clinical evaluation, showing favorable outcomes against all measured endpoints. CS-8958 is a long acting neuraminidase inhibitor (LANI), and is co-owned with Daiichi-Sankyo. The Phase II clinical trial was designed to test the safety and efficacy of CS-8958 in several hundred adult patients who had confirmed, naturally acquired influenza A or B using fever...

2008-07-31 00:00:19

Biota Holdings Limited (ASX: BTA) today announced that its second generation, influenza treatment, CS-8958, has successfully completed its initial Phase II clinical evaluation, showing favourable outcomes against all measured endpoints. The initial Phase III trial is scheduled to commence later this year. CS-8958 is a long acting neuraminidase inhibitor (LANI), and is co-owned with Daiichi-Sankyo. The Phase II clinical trial was designed to test the safety and efficacy of CS-8958 in several...

2006-03-29 12:00:00

WASHINGTON -- GlaxoSmithKline Plc's prescription flu treatment Relenza has won U.S. approval for preventing influenza in adults and children ages 5 and older, regulators said on Wednesday. The inhaled drug already is sold for treating the flu in adults and children. "This approval is a welcome addition to the available defenses against the flu," said Dr. Steven Galson, director of the Food and Drug Administration's Center for Drug Evaluation and Research. Roche AG's Tamiflu, which is a pill,...

2006-03-01 15:35:00

WASHINGTON -- U.S. health officials on Wednesday said they have purchased more than 14 million courses of antiviral treatments from Roche Holding AG and GlaxoSmithKline Plc in preparation for a possible avian flu pandemic among humans. The Department of Health and Human Services ordered 12.4 million courses of Roche's Tamiflu and 1.75 million courses of Glaxo's Relenza, it said in a statement. The agency has already purchased 5.5 million courses of antiviral drugs for its government...

2006-02-03 08:16:53

CHICAGO (Reuters) - Misuse of two anti-viral drugs in China, Russia and other countries likely led to the development of resistant influenza strains against which the drugs are now nearly useless, health experts said on Thursday. The medicines involved are amantadine and rimantadine, used to treat common seasonal influenza but not intended to combat the avian flu strain that has killed at least 85 people since 2003 and which experts fear could mutate and cause a global pandemic....

2006-01-31 02:15:00

ZURICH -- Swiss drugmaker Roche Holding AG has received approval in the European Union for its Tamiflu treatment to be used to prevent influenza in children aged from one to 12 years, the firm said on Tuesday. Tamiflu, which is also being stockpiled by governments to ward off a bird flu pandemic, is approved in Europe, Japan and the United States as a prescription treatment for seasonal flu. The EU approval, which follows a similar regulatory nod from U.S. authorities in December, allows the...

2006-01-24 12:55:00

By Lisa Richwine WASHINGTON -- Swiss drug maker Roche Holding AG said on Tuesday it had lifted restrictions on shipments of influenza drug Tamiflu that were put in place to prevent hoarding by consumers worried about bird flu. Roche said it was now shipping the oral drug to all markets to fight the seasonal flu widespread in several U.S. states. The company said it previously was distributing Tamiflu only to U.S. cities where a high incidence of influenza was being reported. Roche said it...

2006-01-20 07:55:00

By Tom Armitage ZURICH -- Tamiflu, the drug which many governments have stockpiled to ward off a deadly bird flu pandemic, appears to be an effective treatment for the disease if administered early enough, its maker Roche Holding AG said. Roche said on Friday tests on animals showed Tamiflu could work against the current virus but that more studies were needed into how much Tamiflu should be given in order to effectively combat the virus in humans. "The results suggest that Tamiflu can...

2005-11-16 11:35:00

By Tom Armitage ZURICH (Reuters) - Roche, main producer of the drug thought to be the best defense against a possible pandemic caused by bird flu, has settled a dispute with the drug's inventor over production and royalties, the companies said on Wednesday. Governments have been seeking to stockpile the drug, Tamiflu, as a precaution against the possible outbreak of a human variant of avian flu but drug maker Roche Holding AG has come under pressure over concerns that production could fall...

2005-11-07 16:30:00

NEW YORK -- During outbreaks of influenza A, treating children with the antiviral drug amantadine is likely to be a cost-effective measure if treatment begins within 48 hours of symptom onset, especially if it allows quicker return to school and parents' return to work, investigators report. For influenza B, oseltamivir is more effective than amantadine. However, rapid testing is usually not a cost-effective option, primarily because of its lack of sensitivity. Oseltamivir (Tamiflu) and...


Latest Influenza treatment Reference Libraries

69_d42a67c9e67a58fec0ffaab2b08808b2
2011-01-12 16:27:29

The common cold is a viral disease of the upper respiratory system, caused primarily by rhinoviruses and coronaviruses. Symptoms usually include a cough, sore throat, runny nose, and a fever. There is no known treatment to shorten the duration of the virus yet the cold normally dissipates after 7 to 10 days. It is the most common infectious disease in humans who on average are infected two to four times a year in adults. It can also be called a upper respiratory tract infection. Other...

More Articles (1 articles) »
Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related